The crucial role of spacer groups in macromolecular prodrug design

被引:83
作者
Soyez, H [1 ]
Schacht, E [1 ]
Vanderkerken, S [1 ]
机构
[1] STATE UNIV GHENT,DEPT ORGAN CHEM,POLYMER MAT RES GRP,B-9000 GHENT,BELGIUM
关键词
prodrugs; spacer; oligopeptide; lysosomal enzymes; tritosomes; cis-aconityl; cathepsin;
D O I
10.1016/S0169-409X(96)00400-0
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Conventional chemotherapy has been limited by a lack of cell specificity, resulting in unwanted peripheral toxicities and low therapeutic efficiency. In an attempt to overcome these problems, a variety of systems have been designed which are able to deliver the drug more effectively to the target site. Watersoluble macromolecular prodrugs, covalently linking the drug through a degradable spacer, constitute an interesting possibility. The linker plays a crucial role and must fulfil certain requirements in order to release the free parent drug in the vinicity of the tumor. This review will discuss some general principles related to the design of such polymeric drug carriers and an overview of the effect of the type of spacer on the rate of drug release and the correlated in vitro and in vivo results will be outlined.
引用
收藏
页码:81 / 106
页数:26
相关论文
共 148 条
  • [1] ABUCHOWSKI A, 1984, CANCER BIOCHEM BIOPH, V7, P175
  • [2] Abuchowski A., 1981, ENZYMES DRUGS
  • [3] [Anonymous], 1972, LYSOSOMES LAB HDB
  • [4] BALDWIN RW, 1990, MONOCLONAL ANTIBODIE
  • [5] BARRETT AJ, 1981, METHOD ENZYMOL, V80, P535
  • [6] HIGHER ANTI-TUMOR EFFICACY OF DAUNOMYCIN WHEN LINKED TO DEXTRAN - INVIVO AND INVITRO STUDIES
    BERNSTEIN, A
    HURWITZ, E
    MARON, R
    ARNON, R
    SELA, M
    WILCHEK, M
    [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1978, 60 (02) : 379 - 384
  • [7] BOAG AH, 1994, AM J PATHOL, V144, P585
  • [8] THE X-RAY CRYSTAL-STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN NEUTROPHIL COLLAGENASE INHIBITED BY A SUBSTRATE-ANALOG REVEALS THE ESSENTIALS FOR CATALYSIS AND SPECIFICITY
    BODE, W
    REINEMER, P
    HUBER, R
    KLEINE, T
    SCHNIERER, S
    TSCHESCHE, H
    [J]. EMBO JOURNAL, 1994, 13 (06) : 1263 - 1269
  • [9] RECENT ADVANCES ON THE USE OF BIODEGRADABLE MICROPARTICLES AND NANOPARTICLES IN CONTROLLED DRUG-DELIVERY
    BRANNONPEPPAS, L
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1995, 116 (01) : 1 - 9
  • [10] DEGRADATION OF EXTRACELLULAR-MATRIX PROTEINS BY HUMAN CATHEPSIN-B FROM NORMAL AND TUMOR-TISSUES
    BUCK, MR
    KARUSTIS, DG
    DAY, NA
    HONN, KV
    SLOANE, BF
    [J]. BIOCHEMICAL JOURNAL, 1992, 282 : 273 - 278